文献速递疼痛医学神经外科与老年麻醉

脑动态与疼痛时间总和预测氯胺酮输注对神经病理性疼痛的缓解

Brain Dynamics and Temporal Summation of Pain Predicts Neuropathic Pain Relief from Ketamine Infusion.
PubMed 文献 · Anesthesiology · 2018-01-01

该研究纳入30例难治性神经病理性疼痛患者和健康对照,进行定量感觉测试和静息态功能磁共振,随后接受氯胺酮输注(0.5至2 mg·kg·h,平均1.1 mg·kg·h),每天6小时连续5天,1个月后评估疼痛。约50%患者达到疼痛缓解(≥30%),治疗前疼痛时间总和与氯胺酮疗效相关(ρ=-0.52,P=0.003),且缓解者显著高于未缓解者(中位数200 vs 44,P=0.001);治疗前动态连接亦与疗效相关(ρ=0.51,P=0.004),缓解者显著更高(0.55 vs 0.51,P=0.006);下降性抗伤害系统的动态参与显著介导了疼痛易化与疼痛缓解的关系(95%CI 0.005至0.065)。

要点

  • 治疗前疼痛时间总和越高,氯胺酮缓解神经病理性疼痛的可能性越大。
  • 默认网络与下降性抗伤害通路动态连接越高,越可能从氯胺酮获益。
  • 脑与行为学指标有潜力用于个体化预测氯胺酮镇痛疗效。

核心结论

  • 脑与行为学测量可能用于预测氯胺酮对神经病理性疼痛的疗效并指导个体化治疗。

研究设计与样本

  • 前瞻性研究纳入30例难治性神经病理性疼痛患者和健康对照,进行定量感觉测试和静息态功能磁共振,随后接受氯胺酮输注(0.5至2 mg·kg·h,平均1.1 mg·kg·h)每天6小时连续5天,1个月后评估疼痛。

主要发现

  • 约50%患者达到疼痛缓解(≥30%),缓解者平均缓解61±35%,未缓解者7±14%。
  • 治疗前疼痛时间总和与氯胺酮疗效相关(ρ=-0.52,P=0.003),缓解者中位数200(100,345)显著高于未缓解者44(9,92)(P=0.001)。
  • 治疗前动态连接与氯胺酮疗效相关(ρ=0.51,P=0.004),缓解者均值0.55±0.05显著高于未缓解者0.51±0.03(P=0.006)。
  • 下降性抗伤害系统的动态参与显著介导了疼痛易化与疼痛缓解的关系(95%CI 0.005至0.065)。

临床怎么用

  • 对难治性神经病理性疼痛患者,可考虑用治疗前疼痛时间总和和脑功能连接指标筛选可能从氯胺酮输注获益者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

WHAT WE ALREADY KNOW ABOUT THIS TOPIC: WHAT THIS ARTICLE TELLS US THAT IS NEW: BACKGROUND:: Ketamine is an N-methyl-D-aspartate receptor antagonist that reduces temporal summation of pain and modulates antinociception. Ketamine infusions can produce significant relief of neuropathic pain, but the treatment is resource intensive and can be associated with adverse effects. Thus, it is crucial to select patients who might benefit from this treatment. The authors tested the hypothesis that patients with enhanced temporal summation of pain and the capacity to modulate pain via the descending antinociceptive brain pathway are predisposed to obtain pain relief from ketamine. METHODS: Patients with refractory neuropathic pain (n = 30) and healthy controls underwent quantitative sensory testing and resting-state functional magnetic resonance imaging and then completed validated questionnaires. Patients then received outpatient intravenous ketamine (0.5 to 2 mg · kg · h; mean dose 1.1 mg · kg · h) for 6 h/day for 5 consecutive days. Pain was assessed 1 month later. Treatment response was defined as greater than or equal to 30% pain relief (i.e., reduction in pain scores). We determined the relationship between our primary outcome measure of pain relief with pretreatment temporal summation of pain and with brain imaging measures of dynamic functional connectivity between the default mode network and the descending antinociceptive brain pathway. RESULTS: Approximately 50% of patients achieved pain relief (mean ± SD; Responders, 61 ± 35%; Nonresponders, 7 ± 14%). Pretreatment temporal summation was associated with the effect of ketamine (ρ = -0.52, P = 0.003) and was significantly higher in Responders (median [25th, 75th] = 200 [100, 345]) compared with Nonresponders (44 [9, 92]; P = 0.001). Pretreatment dynamic connectivity was also associated with the clinical effect of ketamine (ρ = 0.51, P = 0.004) and was significantly higher in Responders (mean ± SD, 0.55 ± 0.05) compared with Nonresponders (0.51 ± 0.03; P = 0.006). Finally, the dynamic engagement of the descending antinociceptive system significantly mediated the relationship between pretreatment pain facilitation and pain relief (95% CI, 0.005 to 0.065). CONCLUSIONS: These findings suggest that brain and behavioral measures have the potential to prognosticate and develop ketamine-based personalized pain therapy.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Bosma RL, Cheng JC, Rogachov A, et al. Brain Dynamics and Temporal Summation of Pain Predicts Neuropathic Pain Relief from Ketamine Infusion. Anesthesiology. 2018. PMID: 30199420. doi:10.1097/ALN.0000000000002417

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。